• 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

Program

Preliminary program now available!

The APLAR 2024 official program is scheduled in the Singapore time zone (GMT+8). To check the program times in your location, use a time zone converter

As more information becomes available – this page will be updated so please make sure to check back regularly. 

0730-0800
REGISTRATION
0815-1030
MSK Ultrasound Workshop Day 1
Endorsed by the Chapter of Rheumatologists, College of Physicians, Singapore

View information here
Sponsored by

1030-1045
BREAK
1045-1245
MSK Ultrasound Workshop Day 1
Endorsed by the Chapter of Rheumatologists, College of Physicians, Singapore

View information here
1245-1330
BREAK
1330-1500
MSK Ultrasound Workshop Day 1
Endorsed by the Chapter of Rheumatologists, College of Physicians, Singapore

View information here
1500-1515
BREAK
1515-1715
MSK Ultrasound Workshop Day 1
Endorsed by the Chapter of Rheumatologists, College of Physicians, Singapore

View information here
MSK Ultrasound Workshop Day 2
Endorsed by the Chapter of Rheumatologists, College of Physicians, Singapore

0700 - 0900 hours

View information here
Lupus Workshop

View information here
GRAPPA Symposium
0900 - 1000 hours

View information here
Systemic Sclerosis Workshop
0830 - 1010 hours

View information here
Sponsored by

Sponsored by

Sponsored by

BREAK
MSK Ultrasound Workshop Day 2
Endorsed by the Chapter of Rheumatologists, College of Physicians, Singapore

0915 - 1115 hours

View information here
Immunology Workshop
1030 - 1215 hours

View information here
Lupus Workshop

View information here
GRAPPA Symposium
1020 - 1200 hours

View information here
Systemic Sclerosis Workshop
1025 - 1200 hours

View information here
LUNCH BREAK
MSK Ultrasound Workshop Day 2
Endorsed by the Chapter of Rheumatologists, College of Physicians, Singapore

1230 - 1330 hours

View information here
Immunology Workshop
1315 - 1500 hours

View information here
Bone densitometry - basics for clinical practice workshop

View information here
GRAPPA Symposium
1245 - 1500 hours

View information here
Systemic Sclerosis Workshop
1245 - 1425 hours

View information here
BREAK
MSK Ultrasound Workshop Day 2
Endorsed by the Chapter of Rheumatologists, College of Physicians, Singapore

1330 - 1630 hours

View information here
Immunology Workshop
1520 - 1630 hours

View information here
Bone densitometry - basics for clinical practice workshop

View information here
GRAPPA Symposium
1520 - 1630 hours

View information here
Systemic Sclerosis Workshop
1440 - 1650 hours

View information here
1700-1800
Opening Ceremony
Included in registration. View more information here
1800-1930
Welcome Reception and Official Opening of Exhibition Hall
Included in registration. View more information here
0800-0915
Rheumatoid Arthritis
Chairperson: Ho-Youn Kim
Rheumatology Imaging – It’s values, development and future
Coordinated by the APLAR Imaging SIG
Working together across APLAR
Coordinated by the APLAR COPCORD SIG
Digital health & Telemedicine
Coordinated by the APLAR Digital Health SIG
Defining remission and low disease activity states in RA
Andrew Cope

RA-ILD
Chris Edwards

Q&A
Chairpersons: Gavin Lee Ka Wing and Mona Manghani

How should a rheumatologist use ultrasound in day to day practice for the management of pain
Chow Sook Khuan

Overview of rheumatology ultrasound application, research and training ... where are we moving next? The APLAR's perspective
Fred Joshua

Artificial Intelligence and musculoskeletal imaging
Annamaria Iagnocco

Q&A
Chairperson: Nazrul Islam and Will Taylor

The APLAR Gout Registry
Kanon Jatuworapruk

Crowd sourcing for systemic reviews
Sam Whittle

What we know - overview of rheumatic disease occurrence in APLAR
Arvind Chopra

Panel discussion
Chairpersons: Rebecca Grainger and Sakir Ahmed

Introduction
Rebecca Grainger

Introduction to Computer Vision and its application to Medical Imaging
Dwarikanath Mahapatra

Introduction to large language models and design thinking
Terence Tan

Panel Discussion: How to apply computer vision, LLMs and Design thinking in the context of Rheumatology

Moderator: Sakir Ahmed

Panellists:
Rebecca Grainger
Dwarikanath Mahapatra
Terence Tan
YK Cheng
Anindita Santosa
0915-1045
Plenary session 1
Chairpersons: Yoshiya Tanaka and Tsutomu Takeuchi
Artificial intelligence (AI) in rheumatology
Ernest Choy

Cardiovascular risks in rheumatic diseases
Lai-Shan Tam
1045-1110
Break and poster viewing
1100-1215
Morning symposium 1
Morning symposium 2
Morning symposium 3
Morning symposium 4
Sponsored by Gilead Sciences K.K.
View the Industry Partner Program
1215-1330
Vasculitis
Paediatric
Coordinated by the APLAR Paediatric SIG
Abstract session 1: Inflammatory arthritis 1
Chairperson: Arum Kumar Gupta
Comorbidities of SLE
Coordinated by the APLAR Systemic lupus erythematosus SIG
ANCA vasculitis
Ramnath Misra

Takayasu arteritis
Masayoshi Harigai

Giant Cell Arteritis
Bhaskar Dasgupta

Q&A
Chairpersons: Sumaira Farman and Elizabeth Ang

Lupus Nephritis
Caifeng Li

Monogenic Vasculopathies
Sulaiman Al-Mayouf

Autoinflammatory Skin Disorders
Mark Jean Aan Koh

Q&A
Clinical Efficacy of Seniprutug (BCD-180), anti-TRBV9 therapy for radiographic Axial Spondyloarthritis
Inna Gaydukova

Efficacy and safety of Zasocitinib (tak-279), a selective, oral tyk2 inhibitor: a randomized, placebo-controlled phase 2b trial in psoriatic arthritis
Alan Kivitz

Integration of single-cell multi-omics profiling for investigating treatment response to tumor necrosis factor alpha inhibitors in patients with axial spondyloarthritis
Seulkee Lee

Tofacitinib safety in inflammatory arthritides (Rheumatoid, seronegative and psoriatic arthritis): A real-world cross-sectional single-centre large-number study from India
Madhuri Hulikal Sampathkumar

Assessment of Quality in studies evaluating Telemedicine in Rheumatoid Arthritis using the MAST framework: A systemic literature review
Noreen Nasir

Older people have the highest mortality, hospitalisation rate and rheumatoid medication related adverse drug reaction admission
Charles Inderjeeth
Chairperson: Yoshiya Tanaka and CC Mok

Atherosclerotic vascular disease in SLE
Hwee Siew Howe

Management of thrombotic and obstetric APS in SLE
Syahrul Sazliyana Shaharir

Prevalence of SLE and mechanisms and management of Glucocorticoid-induced osteoporosis
Yoshiya Tanaka

Q&A
1330-1500
Lunch symposium 1
Lunch symposium 2
Break and poster viewing
Sponsored by Boehringer Ingelheim
View the Industry Partner Program
1500-1615
Crystal Arthropathy
SSc session
Coordinated by the APLAR SSc SIG
Abstract session 2: Basic Science
Abstract session 3: Late breaking abstracts
Chairperson: Kunihiro Yamaoka
Diagnosis and co-morbidities of gout and hyperuricemia
James Wei

Advances in therapeutics in gout
Lisa Stamp

Q&A
Chairperson: Grace Ho and Mandana Nikpour

From clinical to molecular stratification of SSc- is precision medicine a reality?
Christopher Denton

Q&A

Management of SSc ILD -what do guidelines recommend?
Dinesh Khanna

Q&A

Not all thickened skin is systemic sclerosis- interactive image quiz
Masataka Kuwana
Synovial mast cells promote the development of rheumatoid arthritis
Yunxuan Lei

Regulation of ccl17 production in monocytes/macropahges and identifying ccl17-inhibiting drugs that can block arthritic pain
Adrian Achuthan

Linc01150 in CD4+T Cells Promotes Lymphocyte Infiltration in Primary Sjogren's Syndrome by Binding to MiR-1207-5p
Xiang Yuan

Deficiency of B7-H4 identifies dysfunction of salivary ducal stem cells, and high infiltration of CD8 + T cell around ducts
Li Wang

Povetacicept (ALPN-303), a Potent Dual BAFF/APRIL Inhibitor, Inhibits Key Inflammatory Pathways and Demonstrates Greater Efficacy in Murine Lupus
Min Bao

Bidirectional Two-Sample Mendelian Randomization Analysis Between Oral Microbiome and Systemic Lupus Erythematosus
Zhixiu Li
1615-1645
Break and poster viewing
1645-1800
Recent update in paediatric rheumatic diseases
APLAR - ACR symposium
Coordinated by the ACR
Cancer screening in myositis
Coordinated by the APLAR Myositis (IIM) SIG
Rheumatoid Arthritis : Challenges & Opportunities
Coordinated by the APLAR Young Rheumatologists
Chairpersons: Christine Bernal and Sulaiman Al-Mayouf

Update in paediatric rheumatic diseases I - JIA
Thaschawee Arkachaisri

Update in paediatric rheumatic diseases II - SLE
Eve Smith

Update in paediatric rheumatic diseases III - JDM, Scleroderma and Vasculitides
Swee Ping Tang

Q&A
Chairpersons: Laniyati Hamijoyo and Yoshiya Tanaka

Basic Science update for RA
V. Michael Holers

CAR-T for Rheumatology
Roberto Caricchio

Q&A
Chairperson:Takahisa Gono and Ho So

Who? How? And when?
Hector Chinoy

How well are we doing?
Iris Tang

Discussion and Q&A
Chairpersons: Himantha Atukorale and Chuanhui Xu

Diagnostic challenges in rheumatoid arthritis
Babur Salim

Q&A

Managing rheumatoid arthritis in pregnancy: challenges and solutions
Ghita Harifi

Q&A

Overview of Rheumatoid Arthritis Registries in the APLAR Region
Catherine Hill

Q&A
0800-0915
Reproductive Health
Chairperson: Mohsen Ghasemzadeh Soroush
Crystal-Induced Arthritis
Coordinated by the APLAR Crystal-Induced Arthritis SIG
Abstract session 4: SLE/Sjogren's/APS
Chairperson: Ronald Man-Lung Yip
SSR-MSR Special Session
Chairperson: Howe Hwee Siew
Practical Tips for The Rheumatologist Dealing With Pregnant Patients
May Ching Soh

Updates on management of high-risk pregnancies in rheumatic diseases
Rong Mu

Q&A
Chairpersons: Jose Paulo Lorenzo and Teng Gim Gee

Allopurinol failure what it is and what can we do about it
Lisa Stamp

Imaging in Crystal Arthropathies. What is new?
Annamaria Iagnocco

Characteristics of gout in Asian countries: insight from the APLAR registry
Kanon Jatuworapruk
Landscape of childhood-onset systemic lupus erythematosus in China, 2016-2021
Sihao Gao

Deep learning based image recognition system of salivary gland ultrasound assisted diagnosis of Primary Sjogren ’s syndrome
Yan Geng

Clinical characteristics of patients with Sjogren's syndrome combined with pulmonary arterial hypertension overlapping or not overlapping other connective tissue diseases Xiaoxuan Sun

Monogenic Defects in Patients with Early-onset Systemic lupus Erythematosus: Our Experience from North India
Mahubala Sharma
Welcome message
Howe Hwee Siew

Feng Pao Hsii Prize in Rheumatology: Best written report on a research project in the field of rheumatology by a medical student
Chew Li Ching

Case presentation by KK Hospital paediatric department
Thaschawee Arkachaisri

Feng Pao-Hsii lecture: Systemic Autoinflammatory Diseases - From childhood to adulthood
Raphaela Goldbach-Mansky
0915-1045
Plenary session 2
What is the next revolution in therapeautics in inflammatory arthritis?
Andrew Cope

Critical challenges and solutions in osteoporosis when charting the path of a silver tsunami
Kenneth Saag
1045-1110
Break and poster viewing
1100-1215
Morning symposium 5
Morning symposium 6
Morning symposium 7
Morning symposium 8
Sponsored by AstraZeneca

View the Industry Partner Program
Sponsored by Celltrion


View the Industry Partner Program
1215-1330
SpA
Vasculitis: Toward better management of vasculitis
Coordinated by the APLAR Vasculitis SIG
Osteoarthritis
Coordinated by the APLAR Osteorarthritis SIG
Genetics: Unlocking the genetic mysteries of rheumatology: a journey into personalised medicine
Coordinated by the APLAR Genetics SIG
Updates in treatment of psoriasis
Sunil Dogra

T2T in SpA
Muhammad Haroon

Q&A
Chairpersons: Masayoshi Harigai and Xinping Tian

Serum and genetic biomarkers of Takayasu arteritis–which are truly useful?
Tsuyoshi Shirai

Management of Polymyalgia Rheumatica -Diagnosis and Therapy
Frank Buttgereit

Behcet's disease - deepening understanding of the pathogenesis and new treatments
Farhad Shahram

Panel discussion
Moderator: Xinping Tian
Panelists: Tsuyoshi Shirai, Frank Buttgereit and Farhad Shahram
Chairpersons: Juan Gonzales and Ester Penserga

OA SIG project on hand OA
Juan Gonzales and Sumapa Chaiamnuay

Updates on latest guidelines
Inoshi Atukorala and Ester Penserga

Latest therapies
Matthew Jiang

Q&A
Chairpersons: Michael Tee and Suleman Khan

APLAR Systematic Review of Pharmacogenetics in Rheumatology
Suleman Khan

Exploring the Association and Molecular Impacts of miR-146a/rs2910164 and miR-196a2/ rs185070757 with Rheumatoid Arthritis
Syed Fazal Jalil

Genotype-Smoking Interaction Analysis of IL17A and IL17F Genes in Rheumatoid Arthritis: Unraveling the Impact of Genetic Variants and Smoking on Disease Susceptibility
Javaid Mehmood Malik

The rs11549465 single nucleotide polymorphism of hypoxia-inducible factor 1A gene confers protection against rheumatoid arthritis susceptibility
Syeda Benish Ali

Q&A
1330-1500
Lunch symposium 3
Lunch symposium 4
Break and poster viewing
1500-1615
Health Technologies and Patient Engagement
Chairperson: Anin Santosa
AxSpA
Coordinated by the APLAR SpA SIG
Osteoporosis
Coordinated by the APLAR Osteoporosis SIG
Abstract session 5: Myositis/Vasculitis/Pain
Chairperson: Yew-Kuang Cheng
Personalised care with the use of enabling technologies
Rebecca Grainger

Patient empowerment in the rheumatology practice
Syed Atiqul Haq

Q&A
Chairperson: Kichul Shin and Katy Leung

Updates in Basic Research for SpA
Tae-Jong Kim

Imaging updates in Spondyloarthritis
Ashish Mathew

SAPHO, differences in East and West
Mitsumasa Kishimoto

Q&A
Chairpersons: Julie Yu and Sumapa Chaiamnuay

2022 Malaysian CPG
Swan Sim Yeap

2023 Japanese CPG
Shintaro Hirata

2022 ACR guideline
Kenneth Saag

Open Forum
Titers of autoantibodies for particular epitope peptides efficiently predict treatment resistance in interstitial lung disease with anti-MDA5 dermatomyositis
Tsuneo Sasai

Analysis of Real-World Usage of Avacopan in Patients with Microscopic Polyangiitis: The Multicenter REVEAL Cohort Study
Yoshida Tsuneyasu

Artificial Intelligence based Modelling of HRCT Thorax for Susceptibility to Infection during Immunosuppression in Connective Tissue Disease-Interstitial Lung Disease
Sakir Ahmed

Catching up with Calcinosis: Analysis of Clinical features and Response to Therapy in a Juvenile Dermatomyositis cohort from North India
Ridhima Aggarwal

Attempting symptomatic alleviation by sensorimotor improvement through medical yoga therapy in fibromyalgia
Aasheesh Kumar

Derivation of a new index to reduce multiple positivity in line immunoassay for myositis specific autoantibodies in inflammatory myopathies
Neeraja Vijayan

Cardiovascular Magnetic Resonance-Based Hierarchical Clustering Elucidates Distinct Stages of Pulmonary Artery Hypertension Associated with Connective Tissue Disease Progression
Xiaoxuan Sun
1615-1645
Break and poster viewing
1645-1800
Allied Health Professional
Chairperson: Sami Salman Altekreeti
APLAR - EULAR symposium
Coordinated by EULAR
Rheumatoid Arthritis
Coordinated by the APLAR Rheumatoid Arthritis SIG
Reproductive Health
Coordinated by the APLAR Reproductive Health SIG
The evidence of an anti-inflammatory diet for patients with inflammatory arthritis
Ng Puay Shi

The role of nurses in advanced care planning for patients with rheumatic diseases
Jamie Lim

Q&A
Chairpersons: Laniyati Hamijoyo and Yoshiya Tanaka

State of the art: axial spondylarthritis
Xenofon Baraliakos

State of the art: psoriatic arthritis
Daniel Aletaha

Q&A
Chairperson: Kunihiro Yamaoka

Title: TBA
Xiaolin Sun

Real-world evidence of JAK inhibitors in Japan
Saegusa Sun
Chairperson: Samar Al Emadi

Fertility and sexual health in rheumatic disease
Latika Gupta

Obstetric outcome in CTD - regional consideration
Samar Al-Emadi

Safety of medication with Empasis on male aspect
Vinod Ravindran

Q&A
VENUE COMING SOON
1930-2130
0800-0915
Infections and Malignancy
Abstract session 6: Inflammatory arthritis 2
Chairperson: Ved Chaturvedi
Challenges to Managing Chronic Musculoskeletal and Rheumatic Diseases
Coordinated by the APLAR Social Commitment and Patient Outreach SIG
How to establish APLAR SS registry and CPG
Coordinated by the APLAR Sjogren SIG
The long-term impact of COVID infections on patients with rheumatic diseases
Ernest Choy

Management of immunotherapy related autoimmune diseases
Andrew Cope

Q&A
Unravelling hormonal dynamics in Juvenile Idiopathic Arthritis: insights into growth restrictions and puberty delays
Sayan Mukherjee

Identify novel druggable proteins for juvenile idiopathic arthritics: A proteome-wide Mendelian randomization study
Shan Luo

In rheumatoid arthritis, which clinically quiescent joints are power Doppler synovitis most frequently encountered in and does disease activity matters?
York Kiat Tan

The Heat Is On: A Pilot Study On Utility Of Infrared Thermography In Daily Rheumatology Practice
Nidhish Chandra M

Nail Fold Capillaroscopy in Healthy Individuals: A Single Centre Cross-sectional Observational Study from Southern India
Anirudh Maslekar

Olokizumab, a direct IL-6 inhibitor, in polyarticular-course juvenile idiopathic arthritis (pcJIA): preliminary results of the Phase 2 open-label clinical trial
Mikhail Kostik
Chairpersons:Nazgul Omurzakova and Syed Atiqul Haq

Social factors affecting drug compliance in chronic diseases
Hideto Kameda

Burnout of Rheumatologists: Global Status, Challenges, Implications, and Solutions
Nighat Mir Ahmad

Living well with AIRDs
Sami Salman Altekreeti

Q&A
Important points of revision of SS CPG in Japan
Toshimasa Shimizu
0915-1045
Plenary session 3: Prof Debashish Danda special lectures
Chairperson: Tsutomu Takeuchi
Advances in understanding and treating vasculitis
Carol Langford

NPSLE - how to make significant impact from weak evidence?
Anselm Mak
1045-1110
Morning tea
1100-1225
SLE
Chairperson: Chit Soe
Osteoporosis Debate
Chairperson: Kenneth Saag
PsA
Coordinated by the APLAR SpA SIG
Auto-inflammatory Diseases in Children and Adults
Chairpersons: Syed Atiqul Haq and Sumaira Farman
CAR-T therapy in autoimmune diseases
Francesca Lim

How to spot, track and kill the wolf? / Biologic therapy, answer to SLE
Nan Shen

Q&A
Osteoporosis in CKD - Treat or Not to Treat?

Sumapa Chaiamnuay (FOR)
Julie Yu (AGAINST)
Chairpersons: Fariz Yahya and M. Ahmed Saeed

APLAR PsA recommendation
Katy Leung

Tapering bDMARDs in PsA
Kichul Shin

Axial PsA, what is new?
Xenofon Baraliakos

Q&A
Auto-inflammatory diseases in children
Raphaela Goldbach-Mansky

Update on treatment of Bechets disease
Wafa Madanat
1225-1355
Lunch symposium 5
Sponsored by Shenzhen YHLO Biotech Co., Ltd.


View the Industry Partner Program
1355-1455
Year In Review
Chairperson: Catherine Hill
Year in review - Basic Science
Seung Cheol Shim

Year in review - Clinical
Chris Edwards
1455-1530